Literature DB >> 15289738

Survival in relation to radiotherapeutic modality for brain metastasis: whole brain irradiation vs. gamma knife radiosurgery.

Ratna Datta1, Ajay Jawahar, Federico L Ampil, Runhua Shi, Anil Nanda, Horacio D'Agostino.   

Abstract

The purpose of this report is to evaluate and compare the survival of patients with brain metastasis (BRM) treated by whole brain irradiation (WBI) using linear energy accelerator (LINAC) and by stereotactic radiosurgery using gamma knife. This study consists of a series of 67 patients with BRM treated with WBI between 1998 and 1999 and 53 patients with BRM treated with gamma knife radiosurgery (GKRS) between 2000 and 2001. A retrospective study of the data was performed and the overall survival between these 2 groups was analyzed. The comparability of these 2 groups was tested by chi2 and t test values. Log-rank test was used in the survival comparison. The 1-year survival rate was 26.3% and 22.6%, and corresponding mean survival was 7.8 months and 6.7 months for WBI and GKRS groups, respectively. There was no statistically significant difference between these 2 groups' survival. It was evident from imaging defined lesions that with GKRS the lesions were reduced, stabilized, or disappeared in 89% of cases. Survival of patients with BRM treated with WBI or GKRS was similar in these series. The present study suggests that good tumor response by GKRS does not translate in longer patient survival.

Entities:  

Mesh:

Year:  2004        PMID: 15289738     DOI: 10.1097/01.coc.0000128863.75360.a5

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  11 in total

1.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

2.  TomoTherapy, Gamma Knife, and CyberKnife Therapies for Patients with Tumours of the Lung, Central Nervous System, or Intra-abdomen: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-09-01

3.  The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.

Authors:  A Gabriella Wernicke; Menachem Z Yondorf; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; John A Boockvar; Susan Pannullo; Philip Stieg; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

4.  Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease.

Authors:  Susan C Pannullo; Justin F Fraser; Jennifer Moliterno; William Cobb; Philip E Stieg
Journal:  J Neurooncol       Date:  2010-12-09       Impact factor: 4.130

Review 5.  Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.

Authors:  Jacob Ruzevick; Lawrence Kleinberg; Daniele Rigamonti
Journal:  Neurosurg Rev       Date:  2013-11-15       Impact factor: 3.042

6.  EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

Authors:  Shinji Shimato; Tetsuya Mitsudomi; Takayuki Kosaka; Yasushi Yatabe; Toshihiko Wakabayashi; Masaaki Mizuno; Norimoto Nakahara; Hisashi Hatano; Atsushi Natsume; Dai Ishii; Jun Yoshida
Journal:  Neuro Oncol       Date:  2006-01-20       Impact factor: 12.300

7.  The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors.

Authors:  Thomas L Ellis; Matthew T Neal; Michael D Chan
Journal:  Int J Surg Oncol       Date:  2011-10-16

Review 8.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mark E Linskey; David W Andrews; Anthony L Asher; Stuart H Burri; Douglas Kondziolka; Paula D Robinson; Mario Ammirati; Charles S Cobbs; Laurie E Gaspar; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

9.  Optically-guided frameless linac-based radiosurgery for brain metastases: clinical experience.

Authors:  Sameer K Nath; Joshua D Lawson; Jia-Zhu Wang; Daniel R Simpson; C Benjamin Newman; John F Alksne; Arno J Mundt; Kevin T Murphy
Journal:  J Neurooncol       Date:  2009-08-23       Impact factor: 4.130

10.  Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases.

Authors:  Young Hee Park; Tae Hyun Kim; Sun-Young Jung; Young-Eun Kim; Jong-Myon Bae; Yeon-Joo Kim; Ji Hoon Choi; Nam Kwon Lee; Sung Ho Moon; Sang Soo Kim; Kyung Hwan Shin; Joo-Young Kim; Dae Yong Kim; Kwan Ho Cho
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.